Adding Precision to Medicine - Annual Report and Accounts 2015

May 31, 2016

We have benefitted from a good performance in all aspects of the business in 2015, in particular biomarker services where there has been strong customer adoption of SysQuant® and TMTcalibrator™ with the focus on Precision Medicine. Considerable scientific progress has been made over the period, particularly in Alzheimer’s disease (Ad) across a number of different areas and these have formed the backcloth to the prominent releases and presentations that we have made at major Ad meetings in the USA and Europe.

Back to News